Novomics is a biomedical science company focusing on molecular diagnostic techniques and assays for various cancers. With the knowledge base of genomic information analysis, we have developed diagnostic algorithms. Our products, nProfiler® 1 Stomach Cancer Assay; molecular diagnostic kit for prognosis prediction of GC and nProfiler® 2 Cancer Variant Assay; companion diagnostic kit for solid cancers, will be commercialized in Korea, China, and Southeast Asia. Currently, we are developing an AI-based Spatial Image Analysis platform for breast and colorectal cancer. Learn more at www.novomics.com